Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 11017 - 11024 of 11439 results
Hurricane Irene, Wage Issues and Inclement Weather
August 26, 2011| Blog| Viewpoint
Retaliation Against Applicant Who Sued Former Employer Does Not Violate FLSA, Says Court
August 23, 2011| Blog| Viewpoint
New York City Council Expands Human Rights Law
August 22, 2011| Blog| Viewpoint
Qui Tam "Seal” Windows Shrinking?
August 22, 2011| Blog| Viewpoint
Privacy Class Actions – It’s Still About the Damages
August 18, 2011| Blog| Viewpoint
Second Circuit Analyzes Scope of Material Adverse Employment Actions in a Family Medical Leave Act Retaliation Claim
August 15, 2011| Blog| Viewpoint
NLRB: Broad Confidentiality Clauses May Be Per Se Unlawful
August 12, 2011| Blog| Viewpoint
News & Press Releases
Venture Mega-Rounds Return to Biotech
September 26, 2024
Member Cheryl Reicin was quoted in WSJ Pro Venture Capital in an article about how venture mega rounds are becoming more frequent in the biotech industry. Specifically, Cheryl discusses the need for startups to be aware of the pressures and implications that may come from larger funding rounds.
Lenovo’s Setback in Ericsson ITC Case May Impact Other SEP Disputes
September 26, 2024
Intellectual Property Division Chair Michael Renaud was quoted by IAM in an article about the ITC case between Ericsson and Lenovo and its potential implications for FRAND negotiations. While most ITC cases involving Standard Essential Patents (SEPs) have resulted in no violation findings, this case could change that.
Mintz Ranked in 2025 Edition of Chambers Canada
September 26, 2024
Mintz announced that it has been ranked in the 2025 edition of Chambers Canada. The firm was rankedin both the Life Sciences and Cannabis Law categories. Six attorneys were also ranked in individual categories including Life Sciences, Private Equity, Investment Funds, Cannabis, and Pensions & Benefits.